BREAKING NEWS: Pfizer asks the FDA to authorize its COVID-19 vaccine for kids aged 5-11
- Pfizer-BioNTech asked the FDA to expand emergency use of its COVID-19 vaccine to Americans between ages 5 and 11
- The vaccine is currently fully approved for those aged 16 and older and authorized for teens aged 12-15
- The FDA is meeting on October 26 to discuss and a decision is expected between Halloween and Thanksgiving
Pfizer Inc and its German partner BioNTech SE have asked the U.S. Food and Drug Administration (FDA) to expand emergency use of its COVID-19 vaccine to include kids between ages five and 11.
When the vaccine was originally authorized for use by the FDA in December 2020, it was only for those aged 16 and older, before being expanded to those aged 12 and older in May.
The FDA is planning to move quickly and has a meeting tentatively scheduled to discuss the matter on October 26.
Officials are expected to make a decision between Halloween and Thanksgiving.
Pfizer-BioNTech asked the FDA to expand emergency use of its COVID-19 vaccine to Americans between ages 5 and 11. Pictured: Marisol Gerardo, 9, is held by her mother as she gets the second dose of the Pfizer vaccine during a clinical trial at Duke Health in Durham, North Carolina, April 2021
This is a breaking news story and will be updated.